Novavax Inc (NVAX)

$9.20 -0.03 (-0.27%)
Market Cap 1.49B
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 3.81
Forward PE N/A
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 3,416,800
Avg Vol 4,612,884
Day's Range N/A - N/A
Shares Out 162.50M
Stochastic %K 78%
Beta 2.58
Analysts Sell
Price Target $12.89

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
700 Quince Orchard Road, Gaithersburg, United States
qUbit_9Vol
qUbit_9Vol Feb. 23 at 5:53 PM
$NVAX volatile biotech compressing if resistance breaks on strong flow sharp move
0 · Reply
marketlimit
marketlimit Feb. 23 at 5:48 PM
$NVAX lmao… what a joke
0 · Reply
Ochayethenoo
Ochayethenoo Feb. 23 at 5:23 PM
$NVAX I'm pretty sure we're unwitting participants in an online psychology experiment.
1 · Reply
CIOBRAN
CIOBRAN Feb. 23 at 5:13 PM
$NVAX from 9.6 to 9.13🤔🤔🥲🥲🥲
0 · Reply
DragonTiger
DragonTiger Feb. 23 at 5:13 PM
$NVAX Simple question, how could a CEO who has worked for the company for 3+ years only own 180K shares stock? It's almost certain that The mfker JJ would rather continue to tap multi-millions $$$ annually from shareholders other than sell out the company.
1 · Reply
Gagethis
Gagethis Feb. 23 at 5:05 PM
$NVAX Because JJ is in on it!!!! That's why!!!!!
0 · Reply
Flo6
Flo6 Feb. 23 at 4:53 PM
$NVAX why red again?
0 · Reply
Gagethis
Gagethis Feb. 23 at 4:35 PM
$NVAX JJ is the kingpin allowing this to happen!!!! He needs to be fired right now!!!!!!!!!!!!
2 · Reply
WhosYourDaddy_
WhosYourDaddy_ Feb. 23 at 4:28 PM
$NVAX If you're not day trading this multiple times a day, you're going to be a bag holder for life.
0 · Reply
ChannelGuru
ChannelGuru Feb. 23 at 4:26 PM
$NVAX Institutional ownership has surged from ~65% to ~78% in the last 6 months. ​The "Smart Money" did not buy 20 million shares to watch JJ run the company into 2028 with 0.8% market share. They bought in to see a Liquidity Event.
1 · Reply
Latest News on NVAX
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Feb 19, 2026, 8:00 AM EST - 4 days ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

Jan 30, 2026, 10:09 AM EST - 24 days ago

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

MRNA

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:15 AM EST - 4 weeks ago

Novavax Announces Entering into a License Agreement with Pfizer

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 4 weeks ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:15 PM EST - 5 weeks ago

Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 6 weeks ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 2 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 3 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

Dec 1, 2025, 9:59 AM EST - 3 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 2:33 PM EST - 3 months ago

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 4:41 PM EST - 3 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Novavax to Participate in Jefferies London Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 3 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 3 months ago

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 8:00 AM EST - 3 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 6, 2025, 7:58 AM EST - 3 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Nov 4, 2025, 7:00 AM EST - 3 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 30, 2025, 8:00 AM EDT - 4 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 22, 2025, 7:00 AM EDT - 4 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Oct 14, 2025, 1:08 PM EDT - 4 months ago

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 14, 2025, 6:09 AM EDT - 4 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Oct 7, 2025, 7:00 AM EDT - 4 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 5 months ago

Novavax Announces Progress on Sanofi Agreement

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 5 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 2:10 PM EDT - 6 months ago

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 4, 2025, 8:00 AM EDT - 6 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax to Participate in the Cantor Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 6 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 27, 2025, 3:07 PM EDT - 6 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 6 months ago

Novavax Announces Convertible Debt Refinancing

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:56 PM EDT - 7 months ago

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 7 months ago

Novavax beats quarterly revenue estimates on milestone payment

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025, 8:00 AM EDT - 7 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 8:00 AM EDT - 7 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Jul 24, 2025, 11:02 AM EDT - 7 months ago

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jul 24, 2025, 8:00 AM EDT - 7 months ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 11, 2025, 8:59 PM EDT - 9 months ago

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 9 months ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 9 months ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 9 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 9 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 9 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Novavax to Participate in Upcoming Investor Conferences

May 29, 2025, 8:00 AM EDT - 9 months ago

Novavax to Participate in Upcoming Investor Conferences

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

May 21, 2025, 8:15 AM EDT - 9 months ago

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 9 months ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 10 months ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 10 months ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 10 months ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 10 months ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 10 months ago

FDA approves Novavax COVID vaccine with new conditions

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

May 14, 2025, 10:46 PM EDT - 10 months ago

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

May 12, 2025, 12:45 PM EDT - 10 months ago

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

qUbit_9Vol
qUbit_9Vol Feb. 23 at 5:53 PM
$NVAX volatile biotech compressing if resistance breaks on strong flow sharp move
0 · Reply
marketlimit
marketlimit Feb. 23 at 5:48 PM
$NVAX lmao… what a joke
0 · Reply
Ochayethenoo
Ochayethenoo Feb. 23 at 5:23 PM
$NVAX I'm pretty sure we're unwitting participants in an online psychology experiment.
1 · Reply
CIOBRAN
CIOBRAN Feb. 23 at 5:13 PM
$NVAX from 9.6 to 9.13🤔🤔🥲🥲🥲
0 · Reply
DragonTiger
DragonTiger Feb. 23 at 5:13 PM
$NVAX Simple question, how could a CEO who has worked for the company for 3+ years only own 180K shares stock? It's almost certain that The mfker JJ would rather continue to tap multi-millions $$$ annually from shareholders other than sell out the company.
1 · Reply
Gagethis
Gagethis Feb. 23 at 5:05 PM
$NVAX Because JJ is in on it!!!! That's why!!!!!
0 · Reply
Flo6
Flo6 Feb. 23 at 4:53 PM
$NVAX why red again?
0 · Reply
Gagethis
Gagethis Feb. 23 at 4:35 PM
$NVAX JJ is the kingpin allowing this to happen!!!! He needs to be fired right now!!!!!!!!!!!!
2 · Reply
WhosYourDaddy_
WhosYourDaddy_ Feb. 23 at 4:28 PM
$NVAX If you're not day trading this multiple times a day, you're going to be a bag holder for life.
0 · Reply
ChannelGuru
ChannelGuru Feb. 23 at 4:26 PM
$NVAX Institutional ownership has surged from ~65% to ~78% in the last 6 months. ​The "Smart Money" did not buy 20 million shares to watch JJ run the company into 2028 with 0.8% market share. They bought in to see a Liquidity Event.
1 · Reply
xxtpat
xxtpat Feb. 23 at 4:23 PM
$NVAX I expect a series of positive events in the next months , and the price will then quickly exceed $10.
0 · Reply
avocadro
avocadro Feb. 23 at 4:20 PM
$NVAX I can't remember the last time this turd went up without dipping into red first. This red means nothing! More and more news are coming out. Something is going to give!
0 · Reply
BTC321
BTC321 Feb. 23 at 4:17 PM
$NVAX they can't hold $10 resistance forever
1 · Reply
dkallday
dkallday Feb. 23 at 4:14 PM
$NVAX Big dick ownership
0 · Reply
Tomekk
Tomekk Feb. 23 at 4:09 PM
$NVAX 10$ is near. Great things can happen then.
0 · Reply
RBrown78
RBrown78 Feb. 23 at 3:57 PM
$NVAX Same old shit. But I guess I can't be too mad, this is the first ER in 3 years I am going into above my cost average. If a miracle somehow happens, it will be the first time I can take some kind of profit instead of hoping to just rise and break even.
1 · Reply
Gagethis
Gagethis Feb. 23 at 3:53 PM
$NVAX Pure crap!!! So tired of this shit!!!!!!!!
0 · Reply
Stan_The_Man_Erck
Stan_The_Man_Erck Feb. 23 at 3:53 PM
$NVAX
0 · Reply
pepi0815
pepi0815 Feb. 23 at 3:50 PM
$NVAX hold strong. the day will come. 🥰
1 · Reply
kwinters71
kwinters71 Feb. 23 at 3:50 PM
$NVAX Good catch, so what do we think about this? Do you all think it actually gives MatrixM an "in" at Merck in this division?
0 · Reply
nikeita
nikeita Feb. 23 at 3:42 PM
$NVAX It’s the same game every day, cover at the open and short again during the session, just to keep the price depressed.
0 · Reply
DrSammy
DrSammy Feb. 23 at 3:41 PM
$NVAX Maggie, for Margaret, Matrix-M It Baby w/ Merck!
1 · Reply